Antibodies Inhibit the Protease-mediated Processing of a Malaria Merozoite Surface Protein

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1994 Jul 1

PMID 7516416

Citations 104

Authors

M J Blackman

S Shai

A A Holder

Affiliations

Soon will be listed here.

Abstract

When merozoites of the malaria parasite Plasmodium falciparum are released from infected erythrocytes and invade new red cells, a component of a protein complex derived from the merozoite surface protein 1 (MSP-1) precursor undergoes a single proteolytic cleavage known as secondary processing. This releases the complex from the parasite surface, except for a small membrane-bound fragment consisting of two epidermal growth factor (EGF)-like domains, which is the only part of MSP-1 to be carried into invaded erythrocytes. We report that, a group of monoclonal antibodies specific for epitopes within the EGF-like domains, some interfere with secondary processing whereas others do not. Those that most effectively inhibit processing have previously been shown to prevent invasion. Other antibodies, some of which can block this inhibition, not only do not prevent invasion but are carried into the host cell bound to the merozoite surface. These observations unequivocally demonstrate that the binding of antibody to the COOH-terminal region of MSP-1 on the merozoite surface may not be sufficient to prevent erythrocyte invasion, and show that the interaction of different antibodies with adjacent epitopes within the EGF-like domains of MSP-1 can have distinct biochemical effects on the molecule. Inhibition of MSP-1 processing on merozoites may be a mechanism by which protective antibodies interrupt the asexual cycle of the malaria parasite.

Citing Articles

Atlas of intraerythrocytic development using expansion microscopy.

Liffner B, Cepeda Diaz A, Blauwkamp J, Anaguano D, Frolich S, Muralidharan V Elife. 2023; 12.

PMID: 38108809 PMC: 10727503. DOI: 10.7554/eLife.88088.

A PPP-type pseudophosphatase is required for the maintenance of basal complex integrity in Plasmodium falciparum.

Morano A, Rudlaff R, Dvorin J Nat Commun. 2023; 14(1):3916.

PMID: 37400439 PMC: 10317984. DOI: 10.1038/s41467-023-39435-z.

Atlas of intraerythrocytic development using expansion microscopy.

Liffner B, Cepeda Diaz A, Blauwkamp J, Anaguano D, Frolich S, Muralidharan V bioRxiv. 2023; .

PMID: 36993606 PMC: 10055389. DOI: 10.1101/2023.03.22.533773.

Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion.

Patel P, Dickey T, Hopp C, Diouf A, Tang W, Long C Nat Commun. 2022; 13(1):5888.

PMID: 36202833 PMC: 9537153. DOI: 10.1038/s41467-022-33336-3.

Inner membrane complex proteomics reveals a palmitoylation regulation critical for intraerythrocytic development of malaria parasite.

Qian P, Wang X, Zhong C, Wang J, Cai M, Nguitragool W Elife. 2022; 11.

PMID: 35775739 PMC: 9293000. DOI: 10.7554/eLife.77447.

References

Epstein N, MILLER L, Kaushel D, Udeinya I, Rener J, Howard R . Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J Immunol. 1981; 127(1):212-7. View

Burghaus P, Holder A . Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol. 1994; 64(1):165-9. DOI: 10.1016/0166-6851(94)90144-9. View

Boyle D, Newbold C, Smith C, BROWN K . Monoclonal antibodies that protect in vivo against Plasmodium chabaudi recognize a 250,000-dalton parasite polypeptide. Infect Immun. 1982; 38(1):94-102. PMC: 347702. DOI: 10.1128/iai.38.1.94-102.1982. View

Mrema J, Langreth S, Jost R, Rieckmann K, HEIDRICH H . Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves. Exp Parasitol. 1982; 54(3):285-95. DOI: 10.1016/0014-4894(82)90037-6. View

Majarian W, Daly T, Weidanz W, Long C . Passive immunization against murine malaria with an IgG3 monoclonal antibody. J Immunol. 1984; 132(6):3131-7. View

Pirson P, PERKINS M . Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J Immunol. 1985; 134(3):1946-51. View

Holder A, Lockyer M, Odink K, Sandhu J, Nicholls S, Hillman Y . Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature. 1985; 317(6034):270-3. DOI: 10.1038/317270a0. View

Hadley T, Klotz F, Pasvol G, Haynes J, McGinniss M, Okubo Y . Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion. J Clin Invest. 1987; 80(4):1190-3. PMC: 442364. DOI: 10.1172/JCI113178. View

Hui G, Siddiqui W . Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro. Exp Parasitol. 1987; 64(3):519-22. DOI: 10.1016/0014-4894(87)90068-3. View

10.

Wilson C, Anand R, Clark J, McBride J . Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol. 1987; 9(6):737-46. DOI: 10.1111/j.1365-3024.1987.tb00541.x. View

11.

Lew A, Langford C, Anders R, Kemp D, Saul A, Fardoulys C . A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. Proc Natl Acad Sci U S A. 1989; 86(10):3768-72. PMC: 287221. DOI: 10.1073/pnas.86.10.3768. View

12.

Ramasamy R, Jones G, Lord R . Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen. Immunol Lett. 1990; 23(4):305-9. DOI: 10.1016/0165-2478(90)90077-4. View

13.

Blackman M, HEIDRICH H, Donachie S, McBride J, Holder A . A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med. 1990; 172(1):379-82. PMC: 2188181. DOI: 10.1084/jem.172.1.379. View

14.

Blackman M, Whittle H, Holder A . Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol Biochem Parasitol. 1991; 49(1):35-44. DOI: 10.1016/0166-6851(91)90128-s. View

15.

Blackman M, Holder A . Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol Biochem Parasitol. 1992; 50(2):307-15. DOI: 10.1016/0166-6851(92)90228-c. View

16.

Cooper J, Cooper L, Saul A . Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol Biochem Parasitol. 1992; 51(2):301-12. DOI: 10.1016/0166-6851(92)90080-4. View

17.

Chang S, GIBSON H, Barr P, Hui G . A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol. 1992; 149(2):548-55. View

18.

Riley E, Allen S, Wheeler J, Blackman M, Bennett S, TAKACS B . Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 1992; 14(3):321-37. DOI: 10.1111/j.1365-3024.1992.tb00471.x. View

19.

MILLER L, Roberts T, Shahabuddin M, McCutchan T . Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol. 1993; 59(1):1-14. DOI: 10.1016/0166-6851(93)90002-f. View

20.

CHAPPEL J, Holder A . Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol Biochem Parasitol. 1993; 60(2):303-11. DOI: 10.1016/0166-6851(93)90141-j. View